News | June 03, 2014

Cancer treatment equipment and oncology information system to increase efficiency and standard of treatment


June 3, 2014 — Elekta announced it signed an agreement to provide the Centre Hospitalier de l'Universite de Montreal (University of Montreal Health Centre, or CHUM) with advanced linear accelerators and software. The order, resulting from a competitive tender process, is valued at more than $20 million USD and was booked during Elekta's fourth quarter of its fiscal year 2013/14.

The CHUM was formed through the merger of three teaching hospitals, including the 372-year old Hotel-Dieu Hospital. It is one of the largest hospitals in Canada and a leading academic center in the province of Quebec. To increase the efficiency of its new integrated cancer center, the CHUM has chosen the Mosaiq oncology information system (OIS) to manage the complete spectrum of oncology treatments in a single patient record accessible by its 17 multidisciplinary teams across multiple locations.

The partnership agreement also includes Infinity linear accelerators (linacs) with Agility multileaf collimators (MLCs). At the core of a new radiotherapy treatment platform, this technology will offer CHUM's clinicians superior dose conformance and treatment speed as well as high-resolution beam shaping. For patients, it means safer, faster treatment with less risk of damage to healthy tissue.

David Roberge, M.D., head of radiation oncology at CHUM, said, "We chose Elekta, not simply for the advanced capabilities of its linear accelerators, but because of our shared vision for improving cancer management. Together, we will better integrate our cancer care activities — whether it be clinical research, screening, surgery, systemic therapy, radiation, survivorship or palliative care. Mosaiq will ensure that patients have the most efficient management options available."

For more information: www.elekta.com


Related Content

News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
Subscribe Now